To hear the management report by the board of directors of the Company (the Board of Directors ) for the year ended December 31, 2020.
To hear the report by the approved statutory auditor of the Company in respect of the financial statements of the Company for the year ended December 31, 2020.
To approve the financial statements (annual accounts: balance sheet, statement of profit and loss and annexes) of the Company for the year ended December 31, 2020.
To give discharge to the members of the Board of Directors (the Directors ) and the Company s auditor for the fiscal year ended December 31, 2020.
Approval of fees in respect of the independent Directors services of up to 16 000 euros (including VAT) per director per annum due for the financial year ending December 31, 2021;
To hear the management report by the board of directors of the Company (the Board of Directors ) for the year ended December 31, 2020.
To hear the report by the approved statutory auditor of the Company in respect of the financial statements of the Company for the year ended December 31, 2020.
To approve the financial statements (annual accounts: balance sheet, statement of profit and loss and annexes) of the Company for the year ended December 31, 2020.
To give discharge to the members of the Board of Directors (the Directors ) and the Company s auditor for the fiscal year ended December 31, 2020.
Approval of fees in respect of the independent Directors services of up to 16 000 euros (including VAT) per director per annum due for the financial year ending December 31, 2021;
UAE Tops Region for FDI in Biotechnology Sector Published February 17th, 2021 - 11:00 GMT
Over the past years, the UAE has succeeded in consolidating its position as an attractive destination for investments and business, and today, it is reinforcing its position as a regional and global hub for investment in the sectors of the new economy. (Shutterstock)
Highlights
UAE government is continuing its efforts to enhance the policies that attract foreign investments and expand the scope of incentives and facilities for companies and investors.
The UAE has been ranked first in the Middle East and Africa region in terms of the number of new foreign direct investment (FDI) projects in the country’s biotechnology sector. The UAE was also ranked third in the region in terms of the volume of capital invested in these projects during the period from 2003 to 2020, according to a
UAE leads Mideast and Africa in terms of FDI in Biotech sector
16 Feb 2021
Business Bureau, Gulf Today
The UAE has been ranked first in the Middle East and Africa region in terms of the number of new foreign direct investment (FDI) projects in the country’s Biotechnology sector. The UAE was also ranked third in the region in terms of the volume of capital invested in these projects during the period from 2003 to 2020.
The rankings were revealed by the FDI Markets Index, which was recently issued by the Financial Times’s FDI Intelligence magazine, which specializes in foreign investment trends around the world. The index monitors capital flows and new foreign direct investment projects around the world and identifies the best FDI destinations in the world through reference comparisons.